Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting
Adham S. Bear(University of Pennsylvania), Beatriz M. Carreno(Parker Institute for Cancer Immunotherapy)
Cited by 111
Related Papers
Natural TCRs targeting KRASG12V display fine specificity and sensitivity to human solid tumors
|Journal of Clinical Investigation|2024|24